logo

EVOK

Evoke Pharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

EVOK fundamentals

Evoke Pharma (EVOK) released its earnings on Aug 14, 2025: revenue was 3.75M (YoY +47.00%), missed estimates; EPS was -0.62 (YoY +33.33%), missed estimates.
Revenue / YoY
3.75M
+47.00%
EPS / YoY
-0.62
+33.33%
Report date
Aug 14, 2025
EPS
Revenue

Revenue & Expenses

EVOK has released its 2025 Q3 earnings report, with revenue of 4.28M, reflecting a YoY change of 61.40%, and net profit of -1.16M, showing a YoY change of 11.90%. The Sankey diagram below clearly presents EVOK's revenue sources and cost distribution.

Key Indicators

Evoke Pharma (EVOK) key financial stats and ratios, covering profitability, financial health, and leverage.
Evoke Pharma (EVOK)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Evoke Pharma (EVOK)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Evoke Pharma (EVOK)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Evoke Pharma (EVOK) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Evoke Pharma (EVOK) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield